Screener
InnovAge Holdings, Inc. INNV Cash & Equivalents
Cash & Equivalents at other companies
Other financials
Where this comes from
Reported directly by InnovAge Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.
The source filing: InnovAge Holdings, Inc.’s 10-Q, filed May 8, 2026.
- Filed
- May 7, 2026, 8:00 PM EDT
- Fiscal quarter
- Q3 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001834376-26-000022
| Less: change in cash and restricted cash reclassified to assets held for sale | (82) | — | ||
| INCREASE IN CASH, CASH EQUIVALENTS & RESTRICTED CASH | 31,406 | 3,506 | ||
| CASH, CASH EQUIVALENTS & RESTRICTED CASH, BEGINNING OF PERIOD | 64,140 | 56,960 | ||
| CASH, CASH EQUIVALENTS & RESTRICTED CASH, END OF PERIOD | $ | $95,546 | $ | $60,466 |
| Supplemental Cash Flows Information | ||||
| Interest paid | $ | $3,251 | $ | $3,413 |
| Income taxes paid | $ | $622 | $ | $1 |
| Property and equipment included in accounts payable | $ | $1,158 | $ | $52 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is InnovAge Holdings, Inc.'s cash & equivalents?
- InnovAge Holdings, Inc. (INNV) reported cash & equivalents of $95.55M in Q1 2026.
- How has InnovAge Holdings, Inc.'s cash & equivalents changed year-over-year?
- InnovAge Holdings, Inc.'s cash & equivalents increased by 58.0% year-over-year, from $60.47M to $95.55M.
- What is the long-term trend for InnovAge Holdings, Inc.'s cash & equivalents?
- Over 4 years (2021 to 2025), InnovAge Holdings, Inc.'s cash & equivalents has grown at a -25.1% compound annual growth rate (CAGR), from $203.7M to $64.14M.
- What does cash & equivalents mean?
- Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.
Ask your AI about InnovAge Holdings, Inc.'s cash & equivalents.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude